Clinical Trials Browser

Phase 1/2 × Leukemia × Bendamustine Hydrochloride × Clear all

NCT01088984 2016-05-23

Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Phase 1/2 Completed

43 enrolled 14 charts

Other hematologic neoplasm

Leukemia

NCT00790855 2012-12-04

Bendamustine in Acute Leukemia and MDS

Phase 1/2 Terminated

27 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma